emergencyBreaking NewsBio Protocol (BIO) Surges 123%—Support at $0.030–$0.032 Will Decide Next MoveInstitutional investors are not buying crypto for price gains — they're chasing yieldVanguard's VWOB Swaps Equity Upside for Emerging Market Credit RiskKorea to Deploy AI Caregivers by 2028 as Aging Population Outpaces Human LaborMorgan Stanley's 0.14% Fee Cuts the Cost of Spot Bitcoin ExposureBio Protocol (BIO) Surges 123%—Support at $0.030–$0.032 Will Decide Next MoveInstitutional investors are not buying crypto for price gains — they're chasing yieldVanguard's VWOB Swaps Equity Upside for Emerging Market Credit RiskKorea to Deploy AI Caregivers by 2028 as Aging Population Outpaces Human LaborMorgan Stanley's 0.14% Fee Cuts the Cost of Spot Bitcoin Exposure
DoiDoi
Credit & Lendingexpand_more
Credit CardsPersonal LoansStudent Loans
Markets & Investingexpand_more
Stocks & ETFsCrypto & BlockchainFed & Macro
Retirement & Benefitsexpand_more
401(k) & IRASocial SecurityRetirement Policy
Real Estateexpand_more
Mortgage RatesHousing Market
Financial Foundationexpand_more
Budgeting & SavingInsurance
Latest News
MarketsPortfolio
The Digital Ledger
Credit & Lending
Markets & Investing
Retirement & Benefits
Real Estate
Financial Foundation
Latest News
Dashboards

Institutional Financial Analysis

Home/Markets & Investing/ETF INFLOWS DATA

Bio Protocol (BIO) Surges 123%—Support at $0.030–$0.032 Will Decide Next Move

EB

Ezra Blackwood

ETF inflows data · Apr 17, 2026

Bio Protocol (BIO) Surges 123%—Support at $0.030–$0.032 Will Decide Next Move

Source: DojiDoji Data Terminal

Support between $0.030 and $0.032 will determine the next move for Bio Protocol (BIO), after a 123% rally in seven days pushed the token to $0.04061. This sharp price action has shifted short-term sentiment but remains within a broader bearish structure.

Related BriefJust now
cryptocurrency

Institutional investors are not buying crypto for price gains — they're chasing yield

Institutional investors are not buying crypto for price gains — they're chasing yield. The shift is clear: nearly four out of five institutional investors plan to allocate 2% to 5% of their total assets under management to cryptocurrencies, according to Nomura’s 2026 Digital Asset Institutional Investor Survey. But the goal isn’t just riding price waves. Over two-thirds of respondents want exposure to decentralized finance (DeFi) mechanics like staking, where capital earns returns through network participation. Sixty-five percent are targeting lending and tokenised assets. Sixty-three percent are exploring derivatives and stablecoins. This reflects a broader pivot — from speculation to income generation. Crypto is increasingly seen as a diversification tool on par with stocks, bonds, and commodities, with 65% of institutions now classifying it as such. The focus on yield strategies signals a maturing market, where capital is deployed not for volatility but for utility. Stablecoins, in particular, are emerging as a key conduit. Sixty-three percent of investors see real use cases: managing cash, executing cross-border payments, trading currencies, and investing in tokenised assets. Trust hinges on the issuer — stablecoins backed by major financial institutions in the yen, dollar, and euro are viewed as most credible. Nomura attributes the shift to better risk management, regulatory clarity, and a growing suite of investment products. But the core insight remains: institutions aren’t just entering crypto. They’re reshaping its value proposition.

BIO recently broke out of a prolonged accumulation range between $0.015 and $0.018, with buyers driving the price toward the $0.04 level. The token has gained 93% in 24 hours and more than 120% in seven days, but sellers have quickly responded at key resistance near $0.049, which aligns with the 200-day EMA and Fibonacci levels. This rejection signals that bearish pressure is still active.

Related BriefJust now
digital assets

Morgan Stanley's 0.14% Fee Cuts the Cost of Spot Bitcoin Exposure

Investors now have a spot bitcoin ETF with a 0.14% expense ratio. The fund, trading under the ticker MSBT, began trading on April 8 and tracks the CoinDesk Bitcoin Benchmark 4 PM New York Settlement Rate. This fee structure makes MSBT the cheapest product in its category. The pricing edge allows the fund to attract assets from existing funds, particularly among clients within Morgan Stanley's wealth management network. Within its first week on the market, MSBT attracted more than $100 million in inflows. This is the firm's most successful ETF launch to date.

Open interest in BIO has rebounded from a low of $30 million to $55 million, suggesting fresh positioning and rising interest. Spot outflows, which dominated earlier months, have eased, while inflows have appeared intermittently. This shift supports the idea of stabilization and gradual accumulation.

Related BriefJust now
exchange traded funds

Global ETF Inflows Hit Record $626.42 Billion Despite Market Declines

Year-to-date net inflows into the global ETF industry reached a record $626.42 billion in the first quarter, surpassing the prior peak of $463.51 billion in 2025. This growth occurred while the S&P 500 declined 4.98% in March and developed markets excluding the US fell 10.99% in March. Global ETFs gathered $174.42 billion in net inflows during March alone, marking the 82nd consecutive month of net inflows. Global ETF assets totaled $20.08 trillion at the end of the first quarter. The industry remains highly concentrated, with iShares, Vanguard, and State Street SPDR ETFs controlling 58.3% of total assets. iShares leads with $5.43 trillion, followed by Vanguard at $4.29 trillion, and State Street SPDR ETFs at $1.98 trillion.

The critical next step is whether buyers can defend the $0.030–$0.032 support zone. If this level holds, momentum could rebuild toward the $0.049 resistance ceiling. A strong breakout above $0.049 may trigger a continuation toward $0.061 and higher Fibonacci levels. However, failure to maintain $0.030 support risks a deeper retracement toward $0.026 or even $0.018, which would weaken the current recovery structure significantly.

Related Brief3h ago
mining finance

Unhedged Production and Low AISC Drive Evolution Mining to Net Cash Position

Evolution Mining reached a net cash position during the March 2026 quarter. The company captured this liquidity through an unhedged production strategy, which allows producers to realize 100% of spot price movements during a rally. This performance was amplified by operating leverage, where fixed costs remain constant as revenues scale. Producers with All-in Sustaining Costs (AISC) below USD $1,200 per ounce experienced revenue leverage of 3-5x EBITDA expansion when gold prices moved from USD $1,800 to USD $2,000 per ounce. For every USD $100 per ounce movement above AISC, free cash flow per ounce increases by approximately USD $80-95 after accounting for income tax rates of 25-35%. Evolution Mining achieved its net cash position through higher gold prices combined with consistent operational delivery.

ETF inflows data

The Ledger Morning

The essential intelligence to start your trading day. Delivered 6:00 AM EST.

Join 50,000+ professionals who start their day with The Digital Ledger.

No spam. Unsubscribe anytime.

Read More Analysis

long-term care insurance

Half of Americans under 40 don’t believe they’ll retire — and the numbers explain why

Retirees face a monthly shortfall of $3,049 between average expenses and average Social Security benefits. The average m…

credit card balance transfer

Blended Family Budgets Fail When Ex-Spouses Become the Primary Variable

A $1,200 decision on driving school for a 16-year-old can convert a household budget into an emotional score-keeping exe…

DoiDoi

© 2026 DojiDoji. All rights reserved.

EditorialEditorial GuidelinesCorrections
LegalPrivacy PolicyTerms of Service
DisclosureSEC DisclosuresAd Choice
SocialX (Twitter)LinkedIn